Digital Health Global
JANUARY 31, 2024
the leading technology provider for modern clinical trials, announces results from a new research project with Duke University Department of Population Health Sciences’ Bioethics and Stakeholder (BASE) Lab on the acceptability of enhanced electronic informed consent (eIC) in clinical trials. .–(BUSINESS WIRE)–Medable Inc.,
Lloyd Price
NOVEMBER 21, 2023
Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Palantir's products are helping these organizations to improve patient care, accelerate research, and improve drug development. What are a few likely scenarios for Palantir in Healthcare?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
APRIL 16, 2024
A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment on average of $500K in Phase II and $1.5M
Lloyd Price
MAY 16, 2023
Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Palantir's products are helping these organizations to improve patient care, accelerate research, and improve drug development. What are a few likely scenarios for Palantir in Healthcare? Have a comment?
Digital Health Global
APRIL 10, 2023
Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Co-Founder & President, and Chief Executive Officer. This commercial investment is testament to collaboration across the island of Ireland and the US.
Expert insights. Personalized for you.
88 
Let's personalize your content